WHO ICTRP trial

Study of nutraceutical formulation in healthy subjects with mild damage of lung…

CTRI/2018/10/016195 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2018/10/016195
Public title Study of nutraceutical formulation in healthy subjects with mild damage of lung function due to long term exposure to polluted environment.
Scientific title A Prospective, Randomized, Double Blinded, Placebo-Controlled, Parallel Group, Proof of Concept Study to Assess the Effect of Nutraceutical Formulations in Apparently Healthy Adults with Mildly Impaired Respiratory Function due to Chronic Exposure to Highly Polluted Environment - NA
Primary sponsor Amway India Enterprises Pvt Ltd
Secondary sponsors Siro Clinpharm Pvt Ltd
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Interventions Intervention1: Nutraceutical-1,2,3: 2 tablets twice daily to be consumed orally for 30 days: Botanical formulation of extracts from Adulsa, Turmeric, Tulsi, and glycyrrhiza glabra Control Intervention1: Placebo: 2 tablets twice daily to be…
Registration date Oct 30, 2018
Target size 56
Secondary IDs AM_YH_2018_002, V1 dated 02-Oct-2018
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations